The Poly+5-FU combination treatment led to increased DC and CD8+ T cell infiltration in tumor tissues, supporting the hypothesis that TLR3 activation can counterbalance the immunosuppressive effects of virome depletion. The gene discussed is TLR3; the disease is neoplasm.